Chinanews.com, Shanghai News, September 18 (Reporter Chen Jing) How to spread disease and medical knowledge to more people in simple terms? Popular science education activities and books are important ways.
Professor Cui Yong, vice chairman of the Dermatology and Venereology Branch of the Chinese Medical Association, said in an interview with reporters here on the 18th that medical science can not only help patients "avoid detours" on the road to seeking medical treatment, but also prevent diseases before they occur. As professionals, in addition to providing standardized diagnosis and treatment, doctors should also take the initiative to assume the responsibility of popularizing health science for the public. It is believed that under the organization of the science popularization ability improvement action, the science popularization ability of doctors will be further tempered, and the skin disease science popularization team will be further expanded, so as to promote the continuous improvement of the skin health literacy of the mainland people.
The reporter learned in this interview that the "Three-year Action for Skin Health" section of the "Science Popularization Ability Improvement Action" section was launched, and the science popularization team composed of nearly 100 outstanding dermatology experts across the country will carry out a series of science popularization topics through a combination of online and offline methods, and go to the public on special science popularization activities and disease days to improve the effect of science popularization and education.
At the same time, the skin expert science popularization team will create a benchmark science popularization column through special broadcast activities, so that the popular science content will be more deeply rooted in the hearts of the people. In addition, the team of skin experts will jointly create the popular science book "365 Questions on Atopic Dermatitis" on atopic dermatitis, which will systematically show the "thousands of faces" of atopic dermatitis to the public and patients from different perspectives such as disease, medical treatment, treatment, chronic disease management, food, clothing, housing, transportation and life encyclopedia through comprehensive and professional popular science content and novel and interesting illustrations.
The "Three-Year Action for Skin Health" focuses on the "three aspects" and expands the work of skin health to various fields and dimensions. Not only for ordinary people, for patient groups, but also for grassroots doctors. Talking about the specific implementation measures of medical sinking, Professor Xinghua, chairman of the Dermatology and Venereology Branch of the Chinese Medical Association, introduced that as an important public welfare project in the "Three-year Action for Skin Health", the grassroots tour of high-level experts has promoted the sinking of high-quality medical resources by organizing a team of high-level experts to lead a team to visit and go deep into the grassroots to carry out activities such as teaching rounds, discipline construction, medical and drug delivery, and free clinics in grassroots hospitals, so as to improve the ability of grassroots doctors to diagnose and treat skin diseases, popularize skin health knowledge, and help achieve the goal of Healthy China 2030.
"In clinical practice, we have encountered many patients who come to the clinic because they have learned some diagnosis and treatment information through short videos or official account articles, such as the 'miraculous effect' of specific ointments to treat their skin problems, so they buy and use them by themselves, but the result is not only not cured, but more and more serious." Professor Cui Yong introduced that the skin is the largest organ in the human body, but it is also an organ that is easy to be ignored, and doctors should carry the "banner" of medical science popularization, provide timely and authoritative science popularization for the public, and help patients avoid "twists and turns" on the road to medical treatment.
In the interview, Professor Cui Yong introduced atopic dermatitis to reporters. People of every age, from infants and toddlers to elderly patients, can be deeply affected. Patients suffer from severe itching, severe skin lesions, sleep disruption and other diseases for a long time, which affects physical and mental health and quality of life.
Due to the variety of clinical manifestations and the multifactorial influence of the causes of the disease, the "image" of atopic dermatitis is volatile, but in essence, its onset is related to the immune system. Professor Cui Yong explained that on-cause therapy is a key means to achieve the goal of atopic dermatitis treatment, and many innovative drugs (such as biologics and small molecule drugs) have been recommended by many authoritative guidelines at home and abroad, which can accurately target type 2 inflammation, inhibit the core drivers of atopic dermatitis, IL-4 and IL-13, and help patients effectively achieve "causal therapy". In addition, due to the accumulation of rich evidence-based medical evidence and real-world use experience, biologics have been included in the scope of medical insurance reimbursement, providing protection for patients to take drugs for a long time.
Atopic dermatitis is a chronic disease, and patients need to be prepared for long-term combat and fully consider and balance the effect of treatment and long-term safety to avoid recurrence. Experts remind that scientific skin care should also be done in daily life, maintain mental health, and gradually establish a "new ecology" of skin in the "protracted war".
"At present, innovative treatment options such as new targeted therapies have been developed, which have played a breakthrough role in the treatment of skin diseases such as atopic dermatitis." Professor Xinghua introduced that while medical innovation, it also "urges" grassroots medical institutions to continuously improve their diagnosis and treatment capabilities and service levels, help more patients to standardize diagnosis and treatment, and improve their quality of life. However, the popularization of medical technology is still characterized by large regional differences, underdeveloped economy, and urgent need for improvement in remote areas, and the shortage of high-quality medical resources is particularly obvious at the grassroots level.
Xie Lijuan, general manager of the specialty medicine division of the relevant multinational company, said here that the company has long paid attention to the fields of disease science popularization, patient care, doctor-patient communication, and grassroots doctor training in the field of chronic skin diseases, and has also achieved some results. In the future, the company will continue to give full play to its advantages in scientific research platforms and pharmaceutical innovation in the action of improving its scientific popularization capabilities, and support partners such as the government, authoritative experts and scholars, and public welfare organizations to continue to deepen its efforts in the field of type 2 inflammatory skin diseases and immune diseases such as atopic dermatitis, so as to meet the health needs of more patients and effectively help patients achieve the goal of long-term standardized management of diseases. (ENDS)
Editor: Chen Jing